<- Go Home
Cogstate Limited
Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In addition, the company provides Cognigram, a computerized test to aid healthcare professionals for cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Market Cap
AUD 172.7M
Volume
135.8K
Cash and Equivalents
AUD 34.2M
EBITDA
AUD 11.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 28.3M
Profit Margin
59.85%
52 Week High
AUD 1.05
52 Week Low
AUD 0.52
Dividend
N/A
Price / Book Value
3.97
Price / Earnings
24.07
Price / Tangible Book Value
5.12
Enterprise Value
AUD 139.0M
Enterprise Value / EBITDA
12.26
Operating Income
AUD 9.7M
Return on Equity
17.87%
Return on Assets
10.74
Cash and Short Term Investments
AUD 34.2M
Debt
AUD 507.6K
Equity
AUD 44.3M
Revenue
AUD 47.2M
Unlevered FCF
AUD 7.8M
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium